tirzepatide blindness risk A potentially blinding condition is a very rare side effect of the GLP-1 receptor agonist semaglutide (Ozempic, Wegovy, Rybelsus), the European Medicines Agency (EMA) concluded. https://www.medpagetoday.com/ophthalmology/generalophthalmology/115938?trw=no Does GLP-1 Cause Eye Problems?

Reduced anxiety and depression, which are common comorbidities of obesity, may contribute to enhanced libido and sexual satisfaction

Tracking your injections, monitoring your protein intake, and observing how your body responds to each dose matter as much as the medication itself

Cucumbers, tomatoes, watermelon, strawberries, soups, and broths provide both hydration and nutrients

To maintain stable blood sugar amounts, people must consume balanced meals

Head-to-head comparison The cleanest comparison so far is SURPASS-2, which pitted tirzepatide against semaglutide 1 mg in adults with type 2 diabetes (not the obesity dose, but still the most rigorous head-to-head we have)